The latest market report published by Credence Research, Inc. “Biologics Market was valued at US$ 254.9 Bn in 2017, and expected to reach US$ 580.5 Bn by 2026 at a CAGR of 9.5 % during the forecast period from 2018 to 2026.
Credence Research lately added a new report titled “Biologics Market – Industry Size, Global Trends, Growth, Opportunities, Market Share and Market Forecast – 2018 to 2026” to its repository. This latest research study investigates the Biologics market through different segments primarily based on type, application and end-use, market participants, areas and presents country-level evaluation over the forecast period from 2018 to 2026.
Market Insights:
Global biologics market exhibits remunerative growth during the forecast period from 2018 to 2026 due to presence of around 800 biologics in pipeline. The growth attributed is due to incessant expansion in product portfolio with increasing demand for biologics across the globe. Rising prevalence of chronic diseases, unremitting research and development activities and continuous investment in biologics contribute to the overall market growth. According to World Health Organization (WHO), by 2020 chronic diseases would account for 75% of deaths globally. Cancer, autoimmune diseases, and diabetes contribute above 60% of the overall biologics market. In 2016, approximately 50% of new molecular entities approved by the FDA were biologics. Continuous development in cellular & gene therapy further catalyzes the market owing to its high efficacy and therapeutic outcome. CAR-T cell therapies are the latest therapies approved by the FDA for oncology indications.
Browse Here For Full Report Biologics Market – Growth, Future Prospects, and Competitive Landscape, 2018-2026 with ToC: https://www.credenceresearch.com/report/biologics-market
The report on the Biologics market provides in-depth analysis covering key regional trends, market dynamics, and presents the country-level market size of the Biologics industry. Some of the key elements considered during the course of research included product definition, product classification, enterprise structure, a number of participants in the Biologics, etc.
The report consists of market sizes and forecast for the period from 2018 to 2026, and compounded annual growth rate (CAGR%) measured for individual segments and regional markets, competitive landscape of main market players, vital analysis of market dynamics and profiling of key providers collaborating in the Biologics market.
Report Focus: The ‘Biologics – Global Trends, Estimates and Forecasts, 2018-2026’ reviews the latest developments in plastics industry with a perceptive to perceive the near-future growth prospects. The industry is a fragmented market with multiple participants, opens up numerous investment opportunities. The main investment focus is Biologics business. An in-depth analysis throughout the geographic regions gives strategic enterprise intelligence for the industry investments.
Get Sample Copy of this report: https://www.credenceresearch.com/sample-request/59079
The study offers profitable investment techniques for R&D organizations, manufacturing units, distributors, Contract Research Organizations (CROs) and many more in preferred locations.
The report primarily focuses on: Latest Market Trends,
- Region-wise Demand Factor
- Key Growth Areas
- Market Sizes
- Key Competitors Edge
- Investment Strategies
Estimates are primarily based on online surveys using customized questionnaires via our research team. Besides data from government databases, organization websites, press releases & published research reports are also used for estimates.
Geographic Coverage
- North America Biologics Market Revenue and Forecast
- Europe Biologics Market Revenue and Forecast
- Asia Pacific Biologics Market Revenue and Forecast
- Latin America Biologics Market Revenue and Forecast
- Middle East and Africa Biologics Market Revenue and Forecast
Leading Players:
- Merck & Co. Inc.
- AbbVie, Inc.
- AstraZeneca Plc.
- Amgen, Inc.
- Celgene Corporation
- Bristol-Myers Squibb Co.
- Eli Lilly and Company
- Janssen Pharmaceuticals, Inc.
- GlaxoSmithKline Plc.
- Novartis AG
- Pfizer, Inc.
- Novo Nordisk A/S
- Sanofi S.A
- Roche Holding AG
- Takeda Pharmaceutical Co., Ltd
Get Request For Customization: https://www.credenceresearch.com/request-for-customization/59079
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph.: 1-800-361-8290
Website: http://www.credenceresearch.com
No comments:
Post a Comment